GRI Bio, Inc. (GRI)

USD 0.75

(-4.1%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 21.76 Million - - 100 Thousand - -
Cost of Revenue 10.92 Million 206 Thousand 73 Thousand - 735.00 612.00
Gross Profit 10.84 Million -206 Thousand -73 Thousand 100 Thousand -735.00 -612.00
Operating Expenses 11.33 Million 2.23 Million 1.06 Million 4.81 Million 3.15 Million 4.31 Million
Selling, General and Administrative Expenses 8.09 Million 1.99 Million 813 Thousand 1.1 Million 1.27 Million 800.07 Thousand
Research and Development Expenses 3.23 Million 242 Thousand 249 Thousand 3.7 Million 1.88 Million 3.51 Million
Other Expenses - - - - - -
Cost and Expenses 11.38 Million 2.23 Million 1.06 Million 4.88 Million 3.15 Million 4.31 Million
Operating Income -11.38 Million -2.23 Million -1.06 Million -4.78 Million -3.15 Million -4.31 Million
Interest Expense 2.08 Million 653 Thousand 547 Thousand 34 Thousand 197.02 Thousand -
Income Tax Expense 2.76 Million 325 Thousand -50 Thousand -131.29 Thousand 5.00 -2.00
Earnings before Tax -13.03 Million -3.21 Million -1.55 Million -4.82 Million -3.46 Million -4.31 Million
Net Income -13.03 Million -3.54 Million -1.5 Million -4.82 Million -3.46 Million -4.31 Million
Earnings Per Share Basic -28.25 -8.43 -4.65 -14.87 -10.68 -1728.57
Earnings Per Share Diluted -28.25 -8.43 -4.65 -14.87 -10.68 -1728.57
Weighted Average Shares Outstanding 461.56 Thousand 420 Thousand 324.42 Thousand 324.33 Thousand 324.33 Thousand 2494.92
Weighted Average Shares Outstanding (Diluted) 461.56 Thousand 420 Thousand 324.42 Thousand 324.33 Thousand 324.33 Thousand 2494.92
Gross Margin 0.50 - - 1.00 - -
EBIT Margin -0.50 - - -47.13 - -
Profit Margin -0.60 - - -48.22 - -
EBITDA -10.89 Million -2.51 Million -9.21 Million -4.71 Million -3.26 Million -4.31 Million
Earnings Before Tax Margin -0.52 - - -47.88 - -

Income Statement Charts